TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Faruqi & Faruqi, Llp
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Telix Pharmaceuticals is under investigation for potential securities law violations related to misleading statements about prostate cancer therapeutic candidates and supply chain quality. The company received an SEC subpoena and an FDA Complete Response Letter, causing significant stock price drops.

Insights
TLX   negative

Company faced SEC subpoena, FDA regulatory challenges, stock price dropped over 13-21%, and potential securities law violations alleged in class action lawsuit